BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Prognosis
69 results:

  • 1. Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
    Zechel C; Loy M; Wegner C; Dahlke E; Soetje B; Baehr L; Leppert J; Ostermaier JJ; Lueg T; Nielsen J; Elßner J; Willeke V; Marzahl S; Tronnier V; Madany Mamlouk A
    PLoS One; 2024; 19(2):e0291368. PubMed ID: 38306361
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4/integrin β1 signalling axis.
    Huang YH; Wang WL; Wang PH; Lee HT; Chang WW
    Int J Biol Sci; 2024; 20(1):265-279. PubMed ID: 38164180
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ITGA2 as a prognostic factor of glioma promotes GSCs invasion and EMT by activating STAT3 phosphorylation.
    Zhang J; Li R; Zhang H; Wang S; Zhao Y
    Carcinogenesis; 2024 Apr; 45(4):235-246. PubMed ID: 38142122
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MYEF2: an immune infiltration-related prognostic factor in IDH-wild-type glioblastoma.
    Zhang Y; Wen Y; Nie J; Wang T; Wang G; Gao Q; Cao Y; Wang H; Qi S; Xie S
    Aging (Albany NY); 2023 Aug; 15(15):7760-7780. PubMed ID: 37556355
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker.
    Martínez-Bosch N; Vilariño N; Alameda F; Mojal S; Arumí-Uria M; Carrato C; Aldecoa I; Ribalta T; Vidal N; Bellosillo B; Menéndez S; Del Barco S; Gallego O; Pineda E; López-Martos R; Hernández A; Mesia C; Esteve-Codina A; de la Iglesia N; Balañá C; Martínez-García M; Navarro P
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980184
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of sox2.
    Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
    Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. ADAMTS1 as potential prognostic biomarker promotes malignant invasion of glioma.
    Wang S; Zhang J; Wang K; Zhao Y; Liu D
    Int J Clin Oncol; 2023 Jan; 28(1):52-68. PubMed ID: 36371587
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Glioblastoma CD105
    Li J; Ek F; Olsson R; Belting M; Bengzon J
    Acta Neuropathol Commun; 2022 Aug; 10(1):126. PubMed ID: 36038950
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Echinacoside (ECH) suppresses proliferation, migration, and invasion of human glioblastoma cells by inhibiting Skp2-triggered epithelial-mesenchymal transition (EMT).
    Shi S; Qin Y; Chen D; Deng Y; Yin J; Liu S; Yu H; Huang H; Chen C; Wu Y; Zou D; Wang Z
    Eur J Pharmacol; 2022 Oct; 932():175176. PubMed ID: 35995211
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Altered cytoskeletal status in the transition from proneural to mesenchymal glioblastoma subtypes.
    Keller M; Blom M; Conze LL; Guo M; Hägerstrand D; Aspenström P
    Sci Rep; 2022 Jun; 12(1):9838. PubMed ID: 35701472
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.
    Yang H; Wen L; Pan Y; Shan C; Hong W; Wang H; Zhou C; Cai L; Zhou C
    BMC Cancer; 2022 May; 22(1):580. PubMed ID: 35614407
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nuclear respiratory factor 1 transcriptomic signatures as prognostic indicators of recurring aggressive mesenchymal glioblastoma and resistance to therapy in White American females.
    Bhawe K; Das JK; Yoo C; Felty Q; Gong Z; Deoraj A; Liuzzi JP; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Komotar RJ; Roy D
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1641-1682. PubMed ID: 35441887
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications.
    Lopez-Bertoni H; Johnson A; Rui Y; Lal B; Sall S; Malloy M; Coulter JB; Lugo-Fagundo M; Shudir S; Khela H; Caputo C; Green JJ; Laterra J
    Signal Transduct Target Ther; 2022 Feb; 7(1):37. PubMed ID: 35136034
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.
    Ganser K; Eckert F; Riedel A; Stransky N; Paulsen F; Noell S; Krueger M; Schittenhelm J; Beck-Wödl S; Zips D; Ruth P; Huber SM; Klumpp L
    Int J Cancer; 2022 May; 150(10):1722-1733. PubMed ID: 35085407
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
    Lee SH; Kwon HJ; Park S; Kim CI; Ryu H; Kim SS; Park JB; Kwon JT
    PLoS One; 2021; 16(9):e0257375. PubMed ID: 34516577
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tailoring drug co-delivery nanosystem for mitigating U-87 stem cells drug resistance.
    Behrooz AB; Vazifehmand R; Tajudin AA; Masarudin MJ; Sekawi Z; Masomian M; Syahir A
    Drug Deliv Transl Res; 2022 May; 12(5):1253-1269. PubMed ID: 34405338
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prrx1 promotes stemness and angiogenesis via activating TGF-β/smad pathway and upregulating proangiogenic factors in glioma.
    Chen Z; Chen Y; Li Y; Lian W; Zheng K; Zhang Y; Zhang Y; Lin C; Liu C; Sun F; Sun X; Wang J; Zhao L; Ke Y
    Cell Death Dis; 2021 Jun; 12(6):615. PubMed ID: 34131109
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues.
    Yu X; Munoz-Sagredo L; Streule K; Muschong P; Bayer E; Walter RJ; Gutjahr JC; Greil R; Concha ML; Müller-Tidow C; Hartmann TN; Orian-Rousseau V
    Blood; 2021 Sep; 138(12):1067-1080. PubMed ID: 34115113
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Overview and recent advances in the targeting of medulloblastoma cancer stem cells.
    Paul MR; Zage PE
    Expert Rev Anticancer Ther; 2021 Sep; 21(9):957-974. PubMed ID: 34047251
    [No Abstract]    [Full Text] [Related]  

  • 20. SH3BGRL2 functions as a crucial tumor suppressor in glioblastoma tumorigenesis.
    Nie Z; Cai S; Wei Z; Li Y; Bian L; Wang C; Wang C
    Biochem Biophys Res Commun; 2021 Apr; 547():148-154. PubMed ID: 33610914
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.